Not recruitingEUCTR 2011-000682-12

A Long-term, Multicenter, Open-Label, Flexible Dose Continuation Study in Subjects Who Have Completed a Prior Lurasidone Study

This historical record does not confirm current site availability.

Historical research recordMultiple countriesSchizophrenia

The study in practice

Understand this study

What is this study about?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations: Czechia · Lithuania and 1 more location
Study phase: Phase 3

What to know before participating

A point to clarify

This is historical registry information. What is the current study status and protocol?

Study clarity

Things to check before joining

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: 382
Sponsor: Sunovion Pharmaceuticals Inc.
Sponsor type: Other organization
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: Czechia, Lithuania, Slovakia
Age range: Not clearly listed
Official registry ID: EUCTR 2011-000682-12
Official title: Show the full official title
A Long-term, Multicenter, Open-Label, Flexible Dose Continuation Study in Subjects Who Have Completed a Prior Lurasidone Study

Get this study by email

Recruitment & locations

Not recruiting

Czechia · Lithuania · Slovakia

Registry details

Historical country statuses

Czechia — Prematurely Ended
Lithuania — Completed
Slovakia — Completed

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Sunovion Pharmaceuticals Inc.

Is this study still recruiting?

The historical registry lists this study as not recruiting.

Want to explore more studies?

Explore studies